Sanofi India Limited, headquartered in Mumbai, is a part of Sanofi group. Sanofi SA and its wholly owned subsidiary Hoechst AG, are the major shareholders of Sanofi India Limited. Its manufacturing portfolio contains medicines for several therapeutic areas including cardiovascular, thrombotic, metabolic disorders, oncology, disorders of the central nervous system, internal medicine. Its primary business is medicines in the dosage forms of liquid injectables, tablets, capsules, ointments, drops and syrup. In July 2003, company launched Lantus, the world's first and only once a day insulin.
Fexofenadine is an antihistamine. This drug reduces the effects of natural chemical histamines from the body. Fexofenadine relieves the symptoms of seasonal and year around allergies like hay fever in adults and children. Fexofenadine has a quality of fast onset of action, as it attain its therapeutic efficacy in one hour. It aids in relieving the symptoms of allergic reactions like urticaria, itchy red skin, burning sensation and swelling. Fexofenadine is a drug given in the allergic conditions such as sneezing, itchy nose and throat, watery, red and itchy eyes, runny nose that arises in the following conditions such as: